Trial Profile
Comparison of the Anti Xa Activity in the Enoxaparin for Acute Coronary Syndromes Admitted to the Emergency. Randomized Clinical Trial ENOXAMED Versus LOVENOX
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2020
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms ENOXAMED
- 07 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Jul 2014 New trial record